N Engl J Med 387(3):205216 Garvey WT, Frias JP, Jastreboff AM et al (2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Over the past five years, glucagon-like peptide-1 GLP-1 receptor agonists have surged in popularity, primarily for their efficacy in weight loss and diabetes management
You might be wondering why I suddenly switched to using the Lenreey SMGT-GlP-1 Nano Microneedle Essence
[] The newer amylin analogue AM833 (cagrilintide) is a novel long-acting acylated amylin analogue that acts as a non-selective amylin receptor (AMYR) agonist
Though numerous studies provide evidence supporting the association between fungal infection and cancer development and progression, much remains to be explored
Your dedicated GLP-1 care clinician is here to guide you on your journey to a longer, healthier life